Searched for
NATCO PHARMA HYDERABAD
Holding stocks is harder than finding them: 10 mid- and small-caps stocks that may be worth holding on toHolding a stock is not an act of blind faith. It is not refusing to change one’s mind. It is not averaging down because the stock has falle...- Patent Row: Delhi HC refuses to ban Natco Pharma's insecticide saleThe Delhi High Court has refused to stop Natco Pharma from selling an insecticide. FMC Corp had alleged patent infringement. The court note...
- Natco Pharma's Kothur unit classified as 'voluntary action indicated' by US regulatorNatco Pharma Ltd announced that its Kothur unit in Hyderabad received an Establishment Inspection Report (EIR) from the US FDA, classifying...
- Natco Pharma launches generic drug with 180-day exclusivity in USNatco Pharma has launched Bosentan tablets, a generic version of Tracleer, in the US for treating pulmonary arterial hypertension in young ...
- Natco Pharma to buy over 35% in South Africa's Adcock IngramNatco Pharma, based in Hyderabad, is set to acquire a 35.75% stake in Adcock Ingram, South Africa's second-largest drugmaker, for ₹2,000 cr...
- USFDA issues Form 483 with 7 observations to Natco's pharma Hyderabad divisionNatco Pharma announced that its Hyderabad-based pharma division received a Form 483 with seven observations from the USFDA following an ins...
- Delhi HC asks Natco Pharma to pause Risdiplam launch amid patent disputeThe Delhi High Court has ordered Natco Pharma to maintain status quo on the launch of Risdiplam until April 2. Roche, which holds the paten...
- Natco Pharma, others sued in US for generic cancer drugThe company believes this matter is without merit, Natco Pharma said in a statement. Breckenridge is the abbreviated new drug application (...
- Natco Pharma's marketing partner gets USFDA nod for anti-cancer drugNatco Pharma said based on the ANDA filing date, the company believes that it is eligible for 180 days of sole generic marketing exclusivit...
- Natco gets emergency use nod for Baricitinib to treat Covid without trialsIn a statement, the Hyderabad headquartered pharma company said Baricitinib in combination with Remdesivir is used for the treatment of Cov...
- Natco Pharma gets USFDA approval for Visakhapatnam facilityHyderabad-based Natco Pharma Ltd on Tuesday said it has received the final approval from the US health regulator for its first supplemental...
- Natco Pharma Q2 profit plunges 35% to Rs 118 croreTotal income stood at Rs 518.9 crore against Rs 583.5 crore, a decline of 11 per cent.
- USFDA issues 6 observations to Natco Pharma's API facility near HyderabadThe United States Food and Drug Administration (USFDA) conducted inspection at Kothur facility between August 5-9, 2019.
- Aurobindo, Glenmark, Natco get USFDA nod for migraine tabletsNatco said the drug shipments were already made and the product is being marketed by its partner Breckenridge Pharmaceuticals in the US mar...
- Delhi High Court gives Natco Pharma a week to respond to Bristol-Myers Squibb contempt chargesDelhi HC has given Natco Pharma a week's time to respond to the contempt charges slapped by American firm Bristol-Myers Squibb (BMS).
- Older than Dr Reddy's, little-known Natco comes into limelightIt may be older than Dr Reddy's Laboratories, but recognition has come rather belatedly in the day for Hyderabad-based Natco Pharma.
- Natco Pharma shares jump 15% on Dilip Shanghvi stake buy reportsAccording to reports, Shanghvi had bought 3 lakh shares of Natco Pharma at Rs 234 apiece, which represents 1 per cent stake in the company.
- Natco aims to sell 10 m flu capsulesHyderabad-based Natco Pharma expects to sell 10 million capsules of Natflu, the generic version of Tamiflu-Oseltamivir, used to treat swine...
- Natco Pharma launches anti-swine flu drug NatfluDrug maker Natco Pharma today said it has launched anti-swine flu drug Natflu.
- Buzz on Natco Pharma over land bankThe buzz at the Natco Pharma that it has a land bank valued at close to Rs 350 crore near Hyderabad airport. Supporters of the stock claim ...
Load More
